Skip to content
10-Q

Quarterly Report

INHIBIKASE THERAPEUTICS, INC. IKT

0001193125-25-180899

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 7, 2025 74.52M sh
Shares Diluted Q2 2025 · Jun 30, 2025 90.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 89.77M sh
Shares Diluted Q2 2025 · Jun 30, 2024 7.54M sh
Shares Diluted Q2 2025 · Jun 30, 2024 6.94M sh
Capex Q2 2025 · Jun 30, 2025 $13.4K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$9.68M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$8.92M
Stockholders Equity Q2 2025 · Jun 30, 2025 $80.05M
Stockholders Equity Q2 2025 · Mar 31, 2025 $85.73M
Stockholders Equity Q2 2025 · Dec 31, 2024 $94.87M
Stockholders Equity Q2 2025 · Jun 30, 2024 $5.1M
Stockholders Equity Q2 2025 · Mar 31, 2024 $6.78M
Stockholders Equity Q2 2025 · Dec 31, 2023 $10.98M
Current Liabilities Q2 2025 · Jun 30, 2025 $8.8M
Current Liabilities Q2 2025 · Dec 31, 2024 $3.73M
Total Liabilities Q2 2025 · Jun 30, 2025 $8.8M
Total Liabilities Q2 2025 · Dec 31, 2024 $3.73M
Current Assets Q2 2025 · Jun 30, 2025 $88.79M
Current Assets Q2 2025 · Dec 31, 2024 $98.45M
Total Assets Q2 2025 · Jun 30, 2025 $88.85M
Total Assets Q2 2025 · Dec 31, 2024 $98.6M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.11
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.26
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.66
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.38
Eps Basic Q2 2025 · Jun 30, 2025 −$0.11
Eps Basic Q2 2025 · Jun 30, 2025 −$0.26
Eps Basic Q2 2025 · Jun 30, 2024 −$0.66
Eps Basic Q2 2025 · Jun 30, 2024 −$1.38
Sga Expense Q2 2025 · Jun 30, 2025 $5.92M
Sga Expense Q2 2025 · Jun 30, 2025 $11.17M
Sga Expense Q2 2025 · Jun 30, 2024 $1.97M
Sga Expense Q2 2025 · Jun 30, 2024 $4.01M
Rd Expense Q2 2025 · Jun 30, 2025 $5.27M
Rd Expense Q2 2025 · Jun 30, 2025 $15.78M
Rd Expense Q2 2025 · Jun 30, 2024 $3.08M
Rd Expense Q2 2025 · Jun 30, 2024 $5.83M
Net Income Q2 2025 · Jun 30, 2025 −$9.92M
Net Income Q2 2025 · Jun 30, 2025 −$23.59M
Net Income Q2 2025 · Mar 31, 2025 −$13.68M
Net Income Q2 2025 · Jun 30, 2024 −$4.96M
Net Income Q2 2025 · Jun 30, 2024 −$9.61M
Net Income Q2 2025 · Mar 31, 2024 −$4.65M
Operating Income Q2 2025 · Jun 30, 2025 −$10.83M
Operating Income Q2 2025 · Jun 30, 2025 −$25.43M
Operating Income Q2 2025 · Jun 30, 2024 −$5.05M
Operating Income Q2 2025 · Jun 30, 2024 −$9.83M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $0